Giuseppe Penna Selected Research

Giuseppe Penna Research Topics

Disease

10	Inflammation (Inflammations) 10/2021 - 12/2002
7	Autoimmune Diseases (Autoimmune Disease) 05/2009 - 02/2003
5	Neoplasms (Cancer) 11/2021 - 01/2006
5	Prostatitis 09/2009 - 12/2006
3	Colitis 08/2015 - 06/2010
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 04/2010 - 02/2007
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2004 - 02/2003
2	Breast Neoplasms (Breast Cancer) 11/2021 - 03/2007
2	Infections 01/2021 - 02/2014
2	Pelvic Pain 02/2007 - 12/2006
1	COVID-19 01/2022
1	Paralysis (Palsy) 11/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Insulin Resistance 12/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Celiac Disease (Celiac Sprue) 11/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2015
1	Septic Shock (Toxic Shock Syndrome) 08/2015
1	Necrosis 04/2011
1	Hypercalcemia (Milk Alkali Syndrome) 06/2010
1	Ulcerative Colitis 06/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2010
1	Crohn Disease (Crohn's Disease) 06/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2007
1	Osteoporosis 07/2007
1	Secondary Hyperparathyroidism 07/2007
1	Colonic Neoplasms (Colon Cancer) 03/2007
1	Prostatic Neoplasms (Prostate Cancer) 03/2007
1	Carcinogenesis 03/2007
1	Neoplasm Metastasis (Metastasis) 01/2006
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2006
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2002

Drug/Important Bio-Agent (IBA)

10	Calcitriol Receptors (Calcitriol Receptor)IBA 06/2010 - 02/2003
4	LigandsIBA 08/2004 - 12/2002
3	CytokinesIBA 09/2009 - 02/2007
3	BXL628IBA 04/2009 - 12/2006
3	ChemokinesIBA 02/2007 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2007
2	Peptides (Polypeptides)IBA 01/2021 - 08/2007
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2011 - 06/2010
2	Dextrans (Dextran)FDA Link 04/2011 - 06/2010
2	1,25-dihydroxyvitamin DIBA 06/2010 - 03/2007
2	Interleukin-12 (IL 12)IBA 09/2009 - 06/2003
2	Interleukin-8 (Interleukin 8)IBA 04/2009 - 02/2007
2	NF-kappa B (NF-kB)IBA 04/2009 - 08/2004
2	Vitamin D FDA LinkGeneric 08/2008 - 08/2004
2	Calcitriol (Calcijex)FDA LinkGeneric 03/2007 - 01/2006
1	ChitinasesIBA 11/2021
1	Trastuzumab (Herceptin)FDA Link 11/2021
1	LipopolysaccharidesIBA 10/2021
1	viral interferon regulatory factorsIBA 10/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Choline (Choline Chloride)IBA 12/2019
1	Methionine (L-Methionine)FDA Link 12/2019
1	Monoclonal AntibodiesIBA 01/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	Transaminases (Aminotransferases)IBA 11/2015
1	AntigensIBA 09/2015
1	Protein Isoforms (Isoforms)IBA 08/2015
1	APTIBA 02/2014
1	obeticholic acidIBA 04/2011
1	Trinitrobenzenesulfonic AcidIBA 04/2011
1	AutoantigensIBA 09/2009
1	Interleukin-23 (Interleukin 23)IBA 09/2009
1	Hormones (Hormone)IBA 05/2009
1	Interleukin-6 (Interleukin 6)IBA 04/2009
1	rho-Associated KinasesIBA 04/2009
1	Biological ProductsIBA 01/2009
1	ProstateinIBA 08/2007
1	ReninIBA 03/2007
1	Messenger RNA (mRNA)IBA 03/2007
1	SteroidsIBA 12/2006
1	Carrier Proteins (Binding Protein)IBA 12/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2006
1	Pharmaceutical PreparationsIBA 01/2006
1	Epirubicin (Ellence)FDA LinkGeneric 01/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2006
1	NF-KappaB Inhibitor alphaIBA 08/2004
1	Chemokine CCL22IBA 09/2002

Therapy/Procedure

1	Therapeutics 01/2021
1	Rectal Administration 06/2010
1	Immunotherapy 01/2006